Skystar Bio-Pharmaceutical Co (FRA:GNJC) ROCE % : 20.28% (As of Sep. 2014)

View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Skystar Bio-Pharmaceutical Co's annualized ROCE % for the quarter that ended in Sep. 2014 was 20.28%.

Skystar Bio-Pharmaceutical Co ROCE % Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co ROCE % Chart

Skystar Bio-Pharmaceutical Co Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

ROCE %

Get a 7-Day Free Trial

25.33

27.87

20.57

9.79

12.65

Skystar Bio-Pharmaceutical Co Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
ROCE %	Get a 7-Day Free Trial															17.57	10.75	5.30	12.99	20.28

Skystar Bio-Pharmaceutical Co ROCE % Calculation

Skystar Bio-Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2013 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2013 )		(A: Dec. 2012 )		(A: Dec. 2013 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2013 )		(A: Dec. 2012 )		(A: Dec. 2013 )
	=	9.887	/	( ( (88.208 - 13.111)	+	(99.443 - 18.225) )	/ 2 )
	=	9.887	/	( (75.097	+	81.218)	/ 2 )
	=	9.887	/	78.1575
	=	12.65 %

Skystar Bio-Pharmaceutical Co's ROCE % of for the quarter that ended in Sep. 2014 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2014 )		(Q: Jun. 2014 )		(Q: Sep. 2014 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2014 )		(Q: Jun. 2014 )		(Q: Sep. 2014 )
	=	18.236	/	( ( (115.232 - 31.109)	+	(133.168 - 37.487) )	/ 2 )
	=	18.236	/	( ( 84.123	+	95.681 )	/ 2 )
	=	18.236	/	89.902
	=	20.28 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2014) EBIT data.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Skystar Bio-Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (FRA:GNJC) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN

Website

http://www.skystarbio-pharmaceutical.com

Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Headlines

No Headlines